Upstate Active Clinical Trials

Study Title:

Phase II Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Groupwide Phase II Study

What is the purpose of the study?

Study to look at effect of chemotherapy and radiation therapy used to treat younger patients with newly diagnosed central nervous system germ cell tumors.

Upstate Institutional Review Board (IRB) Number:

395888

Study/Protocol ID:

ACNS1123

Study Phase:

II

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01602666

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again